Bibliografía

Selección de artículos publicados hasta 2020 en PubMed utilizando las palabras clave: “varicose veins AND foam sclerotherapy”.

  1. Abbassi-Ghadi N, Hafez H.
    Ultrasound-guided foam sclerotherapy within a rolling treatment programme is an effective low-cost treatment for superficial venous insufficiency.Phlebology. 2013 Jun;28(4):195-200.

     

  2. Alos J, Carreño P, Lopez JA, Estadella B, Serra-Prat M, Marinel-Lo J.Efficacy and safety of sclerotherapy using polidocanol foam: a controlled clinical trial.Eur J Vasc Endovasc Surg. 2006 Jan;31(1):101-7. Epub 2005 Oct 14.

     

  3. Alder G, Lees T.Foam sclerotherapy.Phlebology. 2015 Nov;30(2 Suppl):18-23.

     

  4. Ali A, Wirth S, Treitl KM, Treitl M.Treatment of male varicoceles by transcatheter polidocanol foam sclerotherapy: evaluation of clinical success, complications, and patients’ satisfaction with regard to alternative techniques.Eur Radiol. 2015 Oct;25(10):2889-97.

     

  5. Ali H, Elbadawy A, Saleh M, Mahmoud O.Mid-term Results of Catheter Directed Foam Sclerotherapy Combined with Tumescent Local Anaesthesia for Treatment of Great Saphenous Vein Incompetence.Eur J Vasc Endovasc Surg. 2017 Sep;54(3):363-368.

     

  6. Ali H, Saleh M, Mohammed W.Efficacy and safety of Duplex-guided polidocanol foam sclerotherapy for venous malformations.Int Angiol. 2017 Jun;36(3):228-236.

     

  7. Asciutto G, Lindblad B.Catheter-directed foam sclerotherapy treatment of saphenous vein incompetence.Vasa. 2012 Mar;41(2):120-4.

     

  8. Badri H, Bhattacharya V.A review of current treatment strategies for varicose veins.Recent Pat Cardiovasc Drug Discov. 2008 Jun;3(2):126-36. Review.

     

  9. Baeshko A, Shestak N, Korytko S.Results of Ultrasound-Guided Foam Sclerotherapy of the Great Saphenous Vein with New Parameters of the Technique.Vasc Endovascular Surg. 2016 Nov;50(8):528-533.

     

  10. Balasundaram I, Al-Hadad I, Rehman K, McCafferty I, Monaghan A.The use of foam sclerotherapy to treat low-flow vascular malformations of the head and neck.J Surg Case Rep. 2014 Sep 24;2014(9).

     

  11. Barrett JM, Allen B, Ockelford A, Goldman MP.Microfoam ultrasound-guided sclerotherapy treatment for varicose veins in a subgroup with diameters at the junction of 10 mm or greater compared with a subgroup of less than 10 mm.Dermatol Surg. 2004 Nov;30(11):1386-90.
  12. Barrett JM, Allen B, Ockelford A, Goldman MP.Microfoam ultrasound-guided sclerotherapy of varicose veins in 100 legs.Dermatol Surg. 2004 Jan;30(1):6-12.

     

  13. Belcaro G, Cesarone MR, Di Renzo A, Brandolini R, Coen L, Acerbi G, Marelli C, Errichi BM, Malouf M, Myers K, Christopoulos D, Nicolaides A, Geroulakos G, Vasdekis S, Simeone E, Ricci A, Ruffini I, Stuard S, Ippolito E, Bavera P, Georgiev M, Corsi M, Scoccianti M, Cornelli U, Caizzi N, Dugall M, Christopoulos D, Veller M, Venniker R, Cazaubon M, Griffin M.Foam-sclerotherapy, surgery, sclerotherapy, and combined treatment for varicose veins: a 10-year, prospective, randomized, controlled, trial (VEDICO trial).Angiology. 2003 May-Jun;54(3):307-15.

     

  14. Benin P, D’Amico C.Foam sclerotherapy with Fibrovein (STD) for the treatment of hemorrhoids, using a flexible endoscope.Minerva Chir. 2007 Aug;62(4):235-40.

     

  15. Bergan J, Cheng V.Foam sclerotherapy of venous malformations.Phlebology. 2007;22(6):299-302.

     

  16. Bergan J, Pascarella L, Mekenas L.Venous disorders: treatment with sclerosant foam.J Cardiovasc Surg (Torino). 2006 Feb;47(1):9-18.

     

  17. Bergan J.Sclerotherapy: a truly minimally invasive technique.Perspect Vasc Surg Endovasc Ther. 2008 Mar;20(1):70-2.

     

  18. Blaise S, Bosson JL, Diamand JM.Ultrasound-guided sclerotherapy of the great saphenous vein with 1% vs. 3% polidocanol foam: a multicentre double-blind randomised trial with 3-year follow-up.Eur J Vasc Endovasc Surg. 2010 Jun;39(6):779-86.

     

  19. Blaise S.[Vascular medicine and foam sclerotherapy for venous malformations].J Med Vasc. 2017 Oct;42(5):315-319.

     

  20. Bootun R, Lane TR, Davies AH.The advent of non-thermal, non-tumescent techniques for treatment of varicose veins.Phlebology. 2016 Feb;31(1):5-14.

     

  21. Bradbury AW, Bate G, Pang K, Darvall KA, Adam DJ.Ultrasound-guided foam sclerotherapy is a safe and clinically effective treatment for superficial venous reflux.J Vasc Surg. 2010 Oct;52(4):939-45.

     

  22. Brittenden J, Cooper D, Dimitrova M, Scotland G, Cotton SC, Elders A, MacLennan G, Ramsay CR, Norrie J, Burr JM, Campbell B, Bachoo P, Chetter I, Gough M, Earnshaw J, Lees T, Scott J, Baker SA, Tassie E, Francis J, Campbell MK.Five-Year Outcomes of a Randomized Trial of Treatments for Varicose Veins.N Engl J Med. 2019 Sep 5;381(10):912-922.

     

  23. Brodersen JP, Geismar U.Catheter-assisted vein sclerotherapy: a new approach for sclerotherapy of the greater saphenous vein with a double-lumen balloon catheter.Dermatol Surg. 2007 Apr;33(4):469-75.

     

  24. Brunken A, Rabe E, Pannier F.Changes in venous function after foam sclerotherapy of varicose veins. Phlebology. 2009 Aug;24(4):145-50. Darvall KA, Bate GR, Adam DJ, Silverman SH, Bradbury AW. Duplex ultrasound outcomes following ultrasound-guided foam sclerotherapy of symptomatic recurrent great saphenous varicose veins.Eur J Vasc Endovasc Surg. 2011 Jul;42(1):107-14.

     

  25. Bush R, Bush P.Evaluation of sodium tetradecyl sulfate and polidocanol as sclerosants for leg telangiectasia based on histological evaluation with clinical correlation.Phlebology. 2017 Aug;32(7):496-500.

     

  26. Bush R, Bush P.Percutaneous foam sclerotherapy for venous leg ulcers.J Wound Care. 2013 Oct;22(10 Suppl): S20-2.

     

  27. Cabrera J. et al.“Ultrasound-Guided Injection of Polidocanol Microfoam in the Management of Venous Leg Ulcers” Editorial y Portada.Arch Dermatol. Vol 140, June 2004.

     

  28. Cabrera J. et al,“Sclerosants in microfoam. A new approach in angiology” International Angiology, Year 2001– Vol. 20 – N. 04 – December – pag. 322

     

  29. Cabrera J. et al.“Treatment of Varicose Long Saphenous Veins with Sclerosants in Microfoam Form: Long -Term Outcomes”.Phlebology (2000) 15; 19-23.

     

  30. Cabrera J. et al.»Escleroterapia en microespuma: Nuevo concepto en escleroterapia. Resultados a largo plazo”.Revista Panamericana de Flebologia y Linfologia 34, Septiembre 1999 ;29-37

     

  31. Cabrera J. et al.“Nuevo Método de Esclerosis en las Varices Tronculares.Patología Vascular” 1995; vol 1, nº 4, Octubre 1995; 55-71.

     

  32. Campos Gomes CV, Prado Nunes MA, Navarro TP, Dardik A.Elastic compression after ultrasound-guided foam sclerotherapy in overweight patients does not improve primary venous hemodynamics outcomes.J Vasc Surg Venous Lymphat Disord. 2020 Jan;8(1):110-117.

     

  33. Carroll C, Hummel S, Leaviss J, Ren S, Stevens JW, Cantrell A, Michaels J.Systematic review, network meta-analysis and exploratory cost-effectiveness model f randomized trials of minimally invasive techniques versus surgery for varicose veins.Br J Surg. 2014 Aug;101(9):1040-52.

     

  34. Cavezzi A, Mosti G, Campana F, Tessari L, Bastiani L, Urso SU.Catheter Foam Sclerotherapy of the Great Saphenous Vein, with Perisaphenous Tumescence Infiltration and Saphenous Irrigation.Eur J Vasc Endovasc Surg. 2017 Nov;54(5):629-635.

     

  35. Cavezzi A, Mosti G, Colucci R, Quinzi V, Bastiani L, Urso SU.Compression with 23mmHg or 35 mmHg stockings after saphenous catheter foam sclerotherapy and phlebectomy of varicose veins: A randomized controlled study.Phlebology. 2019 Mar;34(2):98-106.

     

  36. Coleridge Smith P.Saphenous ablation: sclerosant or sclerofoam? Semin Vasc Surg. 2005 Mar;18(1):19-24.Review. PubMed PMID: 15791549.

     

  37. Coleridge Smith P.Sclerotherapy and foam sclerotherapy for varicose veins.Phlebology. 2009 Dec;24(6):260-9.

     

  38. Creton D, Uhl JF.Foam sclerotherapy combined with surgical treatment for recurrent varicose veins: short term results.Eur J Vasc Endovasc Surg. 2007 May;33(5):619-24.

     

  39. Critello CD, Fiorillo AS, Cristiano MC, de Franciscis S, Serra R.Effects of sulodexide on stability of sclerosing foams.Phlebology. 2019 Apr;34(3):191-200.

     

  40. Cuffolo G, Hardy E, Perkins J, Hands LJ.The effects of foam sclerotherapy on ulcer healing: a single-centre prospective study.Ann R Coll Surg Engl. 2019 Apr;101(4):285-289.

     

  41. Chang S, Weisse C, Berent AC, Rosen RJ.Use of percutaneous foam sclerotherapy with 1.5% sodium tetradecyl sulfate for treatment of a pelvic limb venous malformation in a dog.J Am Vet Med Assoc. 2020 Jun 15;256(12):1368-1374.

     

  42. Chapman-Smith P, Browne A.Prospective five-year study of ultrasound-guided foam sclerotherapy in the treatment of great saphenous vein reflux.Phlebology. 2009 Aug;24(4):183-8.

     

  43. Chen AW, Liu SH, Huang YY, Wang T.Preliminary Experience With More Stable Polidocanol Foam in Sclerotherapy of Head and Neck Venous Malformations.Dermatol Surg. 2018 Nov;44(11):1421-1426.

     

  44. Chen AW, Liu YR, Li K, Zhang K, Wang T, Liu SH.Efficacy of sclerotherapy with radio-opaque foam guided by digital subtraction angiography for the treatment of complex venous malformations of the head and neck.Br J Oral Maxillofac Surg. 2015 Nov;53(9):809-13.

     

  45. Chen CH, Chiu CS, Yang CH.Ultrasound-guided foam sclerotherapy for treating incompetent great saphenous veins–results of 5 years of analysis and morphologic evolvement study.Dermatol Surg. 2012 Jun;38(6):851-7.

     

  46. Choi SY, Won JY, Kim KA, Lee DY, Lee KH.Foam sclerotherapy using polidocanol for balloon-occluded retrograde transvenous obliteration (BRTO).Eur Radiol. 2011 Jan;21(1):122-9.

     

  47. Christou E, Parsi K.Non-involuting congenital haemangioma of the eyelid: successful treatment with fluroscopic ultrasound guided sclerotherapy and surgical excision.Phlebology. 2014 Feb;29(1):4-8.

     

  48. Darke SG, Baker SJ.Ultrasound-guided foam sclerotherapy for the treatment of varicose veins.Br J Surg. 2006 Aug;93(8):969-74. PubMed PMID: 16739097.

     

  49. Darvall KA, Bate GR, Adam DJ, Bradbury AW.Recovery after ultrasound-guided foam sclerotherapy compared with conventional surgery for varicose veins.Br J Surg. 2009 Nov;96(11):1262-7.

     

  50. Darvall KA, Bate GR, Adam DJ, Silverman SH, Bradbury AW.Duplex ultrasound outcomes following ultrasound-guided foam sclerotherapy of symptomatic primary great saphenous varicose veins.Eur J Vasc Endovasc Surg. 2010 Oct;40(4):534-9.

     

  51. Darvall KA, Bate GR, Adam DJ, Silverman SH, Bradbury AW.Ultrasound-guided foam sclerotherapy for the treatment of chronic venous ulceration: a preliminary study.Eur J Vasc Endovasc Surg. 2009 Dec;38(6):764-9.

     

  52. Darvall KA, Bate GR, Bradbury AW.Patient-reported outcomes 5-8‚years after ultrasound-guided foam sclerotherapy for varicose veins.Br J Surg. 2014 Aug;101(9):1098-104.

     

  53. Darvall KA, Bate GR, Sam RC, Adam DJ, Silverman SH, Bradbury AW.Patients’ expectations before and satisfaction after ultrasound guided foam sclerotherapy for varicose veins.Eur J Vasc Endovasc Surg. 2009 Nov;38(5):642-7.

     

  54. Darvall KA, Bate GR, Silverman SH, Adam DJ, Bradbury AW.Medium-term results of ultrasound-guided foam sclerotherapy for small saphenous varicose veins.Br J Surg. 2009 Nov;96(11):1268-73.

     

  55. Darvall KA, Sam RC, Bate GR, Adam DJ, Silverman SH, Bradbury AW.Photoplethysmographic venous refilling times following ultrasound guided foam sclerotherapy for symptomatic superficial venous reflux: relationship with clinical outcomes.Eur J Vasc Endovasc Surg. 2010 Aug;40(2):267-72.

     

  56. Darvall KA, Sam RC, Bate GR, Silverman SH, Adam DJ, Bradbury AW.Changes in health-related quality of life after ultrasound-guided foam sclerotherapy for great and small saphenous varicose veins.J Vasc Surg. 2010 Apr;51(4):913-20.

     

  57. Davies HO, Popplewell M, Bate G, Kelly L, Darvall K, Bradbury AW.The impact of 2013 UK NICE guidelines on the management of varicose veins at the Heart of England NHS Foundation Trust, Birmingham, UK.Phlebology. 2016 Oct;31(9):612-6.

     

  58. De Maeseneer M.Surgery for recurrent varicose veins: toward a less-invasive approach? Perspect Vasc Surg Endovasc Ther.2011 Dec;23(4):244-9.

     

  59. de-Abreu GCG, Camargo O J√∫nior, de-Abreu MFM, de-Aquino JLB.Ultrasound-guided foam sclerotherapy for severe chronic venous insufficiency.Rev Col Bras Cir. 2017 Sep-Oct;44(5):511-520.

     

  60. Delgado J, Bedoya MA, Gaballah M, Low DW, Cahill AM.Percutaneous sclerotherapy of foot venous malformations: evaluation of clinical response.Clin Radiol. 2014 Sep;69(9):931-8.

     

  61. Devereux N, Recke AL, Westermann L, Recke A, Kahle B.Catheter-directed foam sclerotherapy of great saphenous veins in combination with pre-treatment reduction of the diameter employing the principals of perivenous tumescent local anesthesia.Eur J Vasc Endovasc Surg. 2014 Feb;47(2):187-95.

     

  62. Eckmann DM.Polidocanol for endovenous microfoam sclerosant therapy.Expert Opin Investig Drugs. 2009 Dec;18(12):1919-27.

     

  63. Edwards AG, Baynham S, Lees T, Mitchell DC.Management of varicose veins: a survey of current practice by members of the Vascular Society of Great Britain and Ireland.Ann R Coll Surg Engl. 2009 Jan;91(1):77-80.

     

  64. Epstein D, Gohel M, Heatley F, Davies AH.Cost-effectiveness of treatments for superficial venous reflux in patients with chronic venous ulceration.BJS Open. 2018 May 10;2(4):203-212.

     

  65. Epstein D, Onida S, Bootun R, Ortega-Ortega M, Davies AH.Cost-Effectiveness of Current and Emerging Treatments of Varicose Veins.Value Health. 2018 Aug;21(8):911-920.

     

  66. Ferrara F, Ferrara G, Furino E, Ebner H, Quarto G.A new strategy in sclerotherapy of varicose veins.Ann Ital Chir. 2016;87:381-385.

     

  67. Figueiredo M, de Araujo SP, Figueiredo MF.Late follow-up of saphenofemoral junction ligation combined with ultrasound-guided foam sclerotherapy in patients with venous ulcers.Ann Vasc Surg. 2012 Oct;26(7):977-81.

     

  68. Friedmann DP, Goldman MP, Cruz-Inigo AE.Foam sclerotherapy for reticular veins of the chest: a retrospective review of efficacy and safety.Dermatol Surg. 2015 Jan;41(1):126-30.

     

  69. Frullini A, Cavezzi A.Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications.Dermatol Surg. 2002 Jan;28(1):11-5.

     

  70. Funakoshi H, Shirane S, Toda J.Sclerotherapy using polidocanol foam for a giant splenic cyst.Radiol Case Rep. 2020 Jul 10;15(9):1596-1600.

     

  71. Gandini R, Chiocchi M, Konda D, Pampana E, Fabiano S, Simonetti G.Transcatheter foam sclerotherapy of symptomatic female varicocele with sodium-tetradecyl-sulfate foam.Cardiovasc Intervent Radiol. 2008 Jul-Aug;31(4):778-8

     

  72. Gandini R, Konda D, Abrignani S, Chiocchi M, Da Ros V, Morosetti D, Simonetti G.Treatment of symptomatic high-flow female varicoceles with stop-flow foam sclerotherapy.Cardiovasc Intervent Radiol. 2014 Oct;37(5):1259-67.

     

  73. Gianesini S, Menegatti E, Tacconi G, Scognamillo F, Liboni A, Zamboni P.Echo-guided foam sclerotherapy treatment of venous malformation involving the sciatic nerve.Phlebology. 2009 Feb;24(1):46-7.

     

  74. Gibson K, Gunderson K.Liquid and Foam Sclerotherapy for Spider and Varicose Veins.Surg Clin North Am. 2018 Apr;98(2):415-429.

     

  75. Gibson KD, Ferris BL, Pepper D.Foam sclerotherapy for the treatment of superficial venous insufficiency.Surg Clin North Am. 2007 Oct;87(5):1285-95, xii-xiii.

     

  76. Gillet JL, Lausecker M, Sica M, Guedes JM, Allaert FA.Is the treatment of the small saphenous veins with foam sclerotherapy at risk of deep vein thrombosis?Phlebology. 2014 Oct;29(9):600-7.

     

  77. Giurazza F, Corvino F, Cangiano G, Amodio F, Cavaglià E, Silvestre M, De Magistris G, Tecame S, Niola R.Sclerotherapy of peripheral low-flow vascular malformations: technical aspects and mid-term clinical outcome.Radiol Med. 2018 Jun;123(6):474-480.

     

  78. Gloviczki P, Driscoll DJ.Klippel-Trenaunay syndrome: current management.Phlebology. 2007;22(6):291-8. Review.

     

  79. Gloviczki P, Duncan A, Kalra M, Oderich G, Ricotta J, Bower T, McKusick M, Bjarnason H, Driscoll D.Vascular malformations: an update.Perspect Vasc Surg Endovasc Ther. 2009 Jun;21(2):133-48.

     

  80. Gohel MS, Epstein DM, Davies AH.Cost-effectiveness of traditional and endovenous treatments for varicose veins.Br J Surg. 2010 Dec;97(12):1815-23.

     

  81. Grover G, Tanase A, Elstone A, Ashley S.Chronic venous leg ulcers: Effects of foam sclerotherapy on healing and recurrence.Phlebology. 2016Feb;31(1):34-41.

     

  82. Guevara CJ, Gonzalez-Araiza G, Kim SK, Sheybani E, Darcy MD.Sclerotherapy of Diffuse and Infiltrative Venous Malformations of the Hand and Distal Forearm.Cardiovasc Intervent Radiol. 2016 May;39(5):705-710.

     

  83. Guex JJ, Schliephake DE, Otto J, Mako S, Allaert FA.The French polidocanol study on long-term side effects: a survey covering 3,357 patient years.Dermatol Surg. 2010 Jun;36 Suppl 2:993-1003.

     

  84. Guex JJ.Endovenous chemical (and physical) treatments for varices: what’s new?Phlebology. 2014 May;29(1 suppl):45-48.

     

  85. Hamahata A, Yamaki T, Sakurai H.Outcomes of ultrasound-guided foam sclerotherapy for varicose veins of the lower extremities: a single center experience.Dermatol Surg. 2011 Jun;37(6):804-9.

     

  86. Hamel-Desnos CM, Desnos PR, Ferre B, Le Querrec A.In vivo biological effects of foam sclerotherapy. Eur J Vasc Endovasc Surg.2011 Aug;42(2):238-45. doi: 10.1016/j.ejvs.2011.03.034. Epub 2011 Apr 30. PubMed PMID: 21531587.

     

  87. Hamel-Desnos CM, Gillet JL, Desnos PR, Allaert FA.Sclerotherapy of varicose veins in patients with documented thrombophilia: a prospective controlled randomized study of 105 cases.Phlebology. 2009 Aug;24(4):176-82.

     

  88. Harrison C, Holdstock J, Price B, Whiteley M.Endovenous radiofrequency ablation and combined foam sclerotherapy treatment of multiple refluxing perforator veins in a Klippel-Trenaunay syndrome patient.Phlebology. 2014 Dec;29(10):698-700.

     

  89. Hertzman PA, Owens R.Rapid healing of chronic venous ulcers following ultrasound-guided foam sclerotherapy.Phlebology. 2007;22(1):34-9; discussion 39.

     

  90. Howard JK, Slim FJ, Wakely MC, Emerson LG, Davies CE, Kulkarni SR, Bulbulia RA, Whyman MR, Poskitt KR.Recanalisation and ulcer recurrence rates following ultrasound-guided foam sclerotherapy.Phlebology. 2016 Aug;31(7):506-13.

     

  91. Islamoglu F.An alternative treatment for varicose veins: ligation plus foam sclerotherapy.Dermatol Surg. 2011 Apr;37(4):470-9.

     

  92. Jacquet R.[Treatment of lower limb varicose veins in 2015: The present and the future].Ann Dermatol Venereol. 2015 Aug-Sep;142(8-9):483-92.

     

  93. Jing YX, Wang RH, Liu ZX, Meng QY.Analysis of internal spermatic vein embolization through catheter versus laparoscopic high ligation in treatment of left varicocele. Vascular. 2020 Oct;28(5):583-590. doi: 10.1177/1708538120923548.Epub 2020 May 9. PubMed PMID: 32390559.

     

  94. Jones L, Parsi K.Arteries masquerading as varicose veins: A trap for phlebologists.Phlebology. 2015 Dec;30(10):729-35. un;59(6):1011-1018.

     

  95. Kahle B.[Anatomic challenges of foam sclerotherapy for varicose veins].Hautarzt. 2020 Jan;71(1):20-23.

     

  96. Kahraman N, Özsin KK.Ultrasound-guided catheter-directed foam sclerotherapy can be safely applied for the treatment of great saphenous varicose veins in elderly patients.Vascular. 2020 Oct;28(5):597-603.

     

  97. Kakkos SK, Bountouroglou DG, Azzam M, Kalodiki E, Daskalopoulos M, Geroulakos G.Effectiveness and safety of ultrasound-guided foam sclerotherapy for recurrent varicose veins: immediate results.J Endovasc Ther. 2006 Jun;13(3):357-64.

     

  98. Kamhawy AH, Elbarbary AH, Elhenidy MA, Elwagih AMM.Periulcer Foam Sclerotherapy Injection in Chronic Venous Leg Ulcers Using Near-Infrared Laser for Vein Visualization.Int J Low Extrem Wounds. 2020 Mar;19(1):63-69.

     

  99. Keene DJB, Cervellione RM.Antegrade sclerotherapy in adolescent varicocele patients.J Pediatr Urol. 2017 Jun;13(3):305.e1-305.e6.

     

  100. Khan Kharl RA, Khan NI, Pervaiz HK, Ali K, Haider FE, Sattar S, Ahmad Z, Nasir M, Bajwa M, Siddique A.Foam Sclerotherapy: An Emerging, Minimally Invasive And Safe Modality Of Treatment For Varicose Veins.J Ayub Med Coll Abbottabad. 2019 Oct-Dec;31(Suppl 1)(4):S641-S645.

     

  101. Kiguchi MM, Hager ES, Winger DG, Hirsch SA, Chaer RA, Dillavou ED.Factors that influence perforator thrombosis and predict healing with perforator sclerotherapy for venous ulceration without axial reflux.J Vasc Surg. 2014 May;59(5):1368-76.

     

  102. King JT, O’Byrne M, Vasquez M, Wright D;VANISH-1 Investigator Group. Treatment of Truncal Incompetence and Varicose Veins with a Single Administration of a New Polidocanol Endovenous Microfoam Preparation Improves Symptoms and Appearance.Eur J Vasc Endovasc Surg. 2015 Dec;50(6):784-93.

     

  103. Klode J, Klötgen K, Körber A, Schadendorf D, Dissemond J.Polidocanol foam sclerotherapy is a new and effective treatment for post-operative lymphorrhea and lymphocele.J Eur Acad Dermatol Venereol. 2010 Aug;24(8):904-9.

     

  104. Kolluri R, Hays KU, Gohel MS.Foam Sclerotherapy Augmented Phlebectomy (SAP) Procedure for Varicose Veins: Report of a Novel Technique.EJVES Short Rep. 2018 Nov 16;41:16-18.

     

  105. Kulkarni SR, Slim FJ, Emerson LG, Davies C, Bulbulia RA, Whyman MR, Poskitt KR.Effect of foam sclerotherapy on healing and long-term recurrence in chronic venous leg ulcers.Phlebology. 2013 Apr;28(3):140-6.

     

  106. Kumar S, Bhavana K, Kumar B, Sinha AK, Kumar P.Image Guided Sclerotherapy of Masseteric Venous Malformations.Ann Otol Rhinol Laryngol. 2020 Jun;129(6):548-555.

     

  107. Kumar S, Bhavana K, Kumar S, Kumar P.Ultrasound-guided polidocanol foam sclerotherapy for treating venous malformations.J Clin Ultrasound. 2018 Jan;46(1):23-31.

     

  108. Kurdal AT, Yildirim F, Ozbakkaloglu A, Iskesen I, Tetik O.Ultrasound-guided catheter-directed foam sclerotherapy for great saphenous vein.Minerva Chir. 2015 Feb;70(1):33-6. PubMed PMID: 25650651.

     

  109. Leo M, Stefano R, Raffaele AI.Foam sclerotherapy of the great saphenous vein in association with pre-terminal saphenous junction ligation/division as an office-based procedure: 12-Month results.Phlebology. 2018 Jun;33(5):321-329.

     

  110. Li L, Hong XY, Zeng XQ, Luo PL, Yi Q.Technical feasibility and early results of radiologically guided foam sclerotherapy for treatment of varicose veins.Dermatol Surg. 2011 Jul;37(7):992-8.

     

  111. Li L, Zeng XQ, Li YH.Digital subtraction angiography-guided foam sclerotherapy of peripheral venous malformations.AJR Am J Roentgenol. 2010 May;194(5):W439-44.

     

  112. Li X, Fan L, Ren S, Li X.Outcomes of Foam Sclerotherapy plus Ligation versus Foam Sclerotherapy Alone for Venous Ulcers in Lower Extremities.Ann Vasc Surg. 2017 Nov;45:160-165.

     

  113. Lin F, Zhang S, Sun Y, Ren S, Liu P.The management of varicose veins.Int Surg. 2015 Jan;100(1):185-9.

     

  114. Liu X, Zheng G, Ye B, Chen W, Xie H, Zhang T, Lin J.A retrospective cohort study comparing two treatments for active venous leg ulcers.Medicine (Baltimore). 2020 Feb;99(8):e19317.

     

  115. Liu ZX, Guo PM, Zhang LL, Shi MJ, Wang RH, Meng QY.Efficacy of Endovenous Laser Treatment Combined with Sclerosing Foam in Treating Varicose Veins of the Lower Extremities.Adv Ther. 2019 Sep;36(9):2463-2474.

     

  116. Lloret P, Redondo P, Cabrera J, Sierra A.Treatment of venous leg ulcers with ultrasound-guided foam sclerotherapy: Healing, long-term recurrence and quality of life evaluation.Wound Repair Regen. 2015 May-Jun;23(3):369-78.

     

  117. Markovic JN, Nag U, Shortell CK.Safety and efficacy of foam sclerotherapy for treatment of low-flow vascular malformations in children.J Vasc Surg Venous Lymphat Disord. 2020 Nov;8(6):1074-1082.

     

  118. Memetoğlu ME, Yılmaz M, Kehlibar T, Günay R, Ketenci B, Demirtaş MM, Özhan A, Karakaya C, Güler E.Ultrasonography-guided foam sclerotherapy in patients with small saphenous veil insufficiency.J Vasc Surg Venous Lymphat Disord. 2020 Sep;8(5):799-804.

     

  119. Moritz RK, Reich-Schupke S, Altmeyer P, Stücker M.Polidocanol foam sclerotherapy of persisting postoperative seromas after varicose vein surgery: a series of six cases.Phlebology. 2013 Oct;28(7):341-6.

     

  120. Mukul SK, Singh A, Kumar A, Pandey S, Singh S, Kumar A.Foam Polidocanol Sclerotherapy for Low-Flow Vascular Malformations of Tongue.Ann Maxillofac Surg. 2019 Jul-Dec;9(2):257-260.

     

  121. Mwipatayi BP, Western CE, Wong J, Angel D.Atypical leg ulcers after sclerotherapy for treatment of varicose veins: Case reports and literature review.Int J Surg Case Rep. 2016;25:161-4.

     

  122. Myers K.A history of injection treatments – I the syringe.Phlebology. 2019 Jun;34(5):294-302.

     

  123. Myers KA, Jolley D, Clough A, Kirwan J.Outcome of ultrasound-guided sclerotherapy for varicose veins: medium-term results assessed by ultrasound surveillance.Eur J Vasc Endovasc Surg. 2007 Jan;33(1):116-21. Epub 2006 Oct 24.

     

  124. Myers KA, Jolley D.Factors affecting the risk of deep venous occlusion after ultrasound-guided sclerotherapy for varicose veins.Eur J Vasc Endovasc Surg. 2008 Nov;36(5):602-5.

     

  125. Nael R, Rathbun S.Effectiveness of foam sclerotherapy for the treatment of varicose veins.Vasc Med. 2010 Feb;15(1):27-32.

     

  126. Naik MN, Batra J, Nair AG, Ali MJ, Kaliki S, Mishra DK.Foam sclerotherapy for periorbital dermoid cysts.Ophthalmic Plast Reconstr Surg. 2014 May-Jun;30(3):267-70.

     

  127. Neto FC, de Ara√∫jo GR, Kessler IM, de Amorim RF, Falc√£o DP.Treatment of severe chronic venous insufficiency with ultrasound-guided foam sclerotherapy: a two-year series in a single center in Brazil.Phlebology. 2015 Mar;30(2):113-8.

     

  128. Neto FC, Gomes de Oliveira R, Thomazinho F, Weinhardt Batista AP, Moraes Kessler I.Impact of Great Saphenous Vein Foam Sclerotherapy on Quality of Life and Photoplethysmography Findings in Chronic Venous Insufficiency: One-Year Follow-up.Dermatol Surg. 2020 Mar;46(3):369-375.

     

  129. Neumann HA, Kockaert MA.The treatment of leg telangiectasia.J Cosmet Dermatol. 2003 Apr;2(2):73-81.

     

  130. Nijsten T, van den Bos RR, Goldman MP, Kockaert MA, Proebstle TM, Rabe E, Sadick NS, Weiss RA, Neumann MH.Minimally invasive techniques in the treatment of saphenous varicose veins.J Am Acad Dermatol. 2009 Jan;60(1):110-9.

     

  131. Nitecki S, Bass A.Ultrasound-guided foam sclerotherapy in patients with Klippel-Trenaunay syndrome.Isr Med Assoc J. 2007 Feb;9(2):72-5.

     

  132. Niu CQ, Jiang H, Zhou SY, Shen G, Li HB, Zhang J.[Effect of foam sclerotherapy for the treatment of oropharyngeal venous malformation].Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 Mar 7;53(3):209-213.

     

  133. O’Hare JL, Earnshaw JJ.The use of foam sclerotherapy for varicose veins: a survey of the members of the Vascular Society of Great Britain and Ireland.Eur J Vasc Endovasc Surg. 2007 Aug;34(2):232-5.

     

  134. O’Hare JL, Parkin D, Vandenbroeck CP, Earnshaw JJ.Mid term results of ultrasound guided foam sclerotherapy for complicated and uncomplicated varicose veins.Eur J Vasc Endovasc Surg. 2008 Jul;36(1):109-13.

     

  135. Orsini C, Brotto M.Immediate pathologic effects on the vein wall of foam sclerotherapy.Dermatol Surg. 2007 Oct;33(10):1250-4. PubMed PMID: 17903159.

     

  136. Pang KH, Bate GR, Darvall KA, Adam DJ, Bradbury AW.Healing and recurrence rates following ultrasound-guided foam sclerotherapy of superficial venous reflux in patients with chronic venous ulceration.Eur J Vasc Endovasc Surg. 2010 Dec;40(6):790-5.

     

  137. Park HS, Do YS, Park KB, Kim KH, Woo SY, Jung SH, Kim DI, Kim YW, Hyun D, Cho SK, Choo IW.Clinical outcome and predictors of treatment response in foam sodium tetradecyl sulfate sclerotherapy of venous malformations.Eur Radiol. 2016 May;26(5):1301-10.

     

  138. Parsi K, Hannaford P.Intra-arterial injection of sclerosants: Report of three cases treated with systemic steroids. Phlebology. 2016 May;31(4):241-50. Carr SC. Diagnosis and management of venous ulcers.Perspect Vasc Surg Endovasc Ther. 2008 Mar;20(1):82-5.

     

  139. Parsi K.Catheter-directed sclerotherapy.Phlebology. 2009 Jun;24(3):98-107.

     

  140. Pascarella L, Bergan JJ, Mekenas LV.Severe chronic venous insufficiency treated by foamed sclerosant.Ann Vasc Surg. 2006 Jan;20(1):83-91. PubMed PMID: 16378144.

     

  141. Rabe E, Otto J, Schliephake D, Pannier F.Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial.Eur J Vasc Endovasc Surg. 2008 Feb;35(2):238-45. Epub 2007 Nov 7.

     

  142. Rabe E, Pannier F.Sclerotherapy of varicose veins with polidocanol based on the guidelines of the German Society of Phlebology.Dermatol Surg. 2010 Jun;36 Suppl 2:968-75. doi: 10.1111/j.1524-4725.2010.01495.x.

     

  143. Redondo P, Bastarrika G, Sierra A, Mart√nez-Cuesta A, Cabrera J.Efficacy and safety of microfoam sclerotherapy in a patient with Klippel-Trenaunay syndrome and a patent foramen ovale.Arch Dermatol. 2009 Oct;145(10):1147-51.

     

  144. Reich-Schupke S, Altmeyer P, Stücker M.Triple-lumen double-balloon catheter for foam sclerotherapy of the great saphenous vein: critical review on preliminary results.Phlebology. 2010 Oct;25(5):241-5.

     

  145. Reich-Schupke S, Doerler M, Altmeyer P, Stücker M.Foam sclerotherapy with enoxaparin prophylaxis in high-risk patients with postthrombotic syndrome.Vasa. 2013 Jan;42(1):50-5.

     

  146. Reich-Schupke S, Weyer K, Altmeyer P, Stücker M.Treatment of varicose tributaries with sclerotherapy with polidocanol 0.5 % foam.Vasa. 2010 May;39(2):169-74.

     

  147. Ribeiro MC, de Mattos Camargo Grossmann S, do Amaral MBF, de Castro WH, Navarro TP, Procopio RJ, da Silva TA, de Nazaré Alves de Oliveira Kato C, Mesquita RA.Effectiveness and safety of foam sclerotherapy with 5% ethanolamine oleate in the treatment of low-flow venous malformations in the head and neck region: a case series.Int J Oral Maxillofac Surg. 2018 Jul;47(7):900-907.

     

  148. Ricci S, Georgiev M, Jawien A, Zamboni P.Sciatic nerve varices.Eur J Vasc Endovasc Surg. 2005 Jan;29(1):83-7.

     

  149. Sadick NS.Advances in the treatment of varicose veins: ambulatory phlebectomy, foam sclerotherapy, endovascular laser, and radiofrequency closure Dermatol Clin.2005 Jul;23(3):443-55, vi. Review.

     

  150. Sadick NS.Advances in the treatment of varicose veins: ambulatory phlebectomy, foam sclerotherapy, endovascular laser, and radiofrequency closure.Adv Dermatol. 2006;22:139-56. Review.

     

  151. Saunders RS, Scansen BA, Jung SS, Khabiri H, Wilkie DA.Use of an intravenous sclerosing foam (3% sodium tetradecyl sulfate) for treatment of orbital varix in a dog.Vet Ophthalmol. 2018 Mar;21(2):194-198.

     

  152. Schuller-Petrović S, Pavlović MD, Schuller S, Schuller-Lukic B, Adamic MTelangiectasias resistant to sclerotherapy are commonly connected to a perforating vessel.Phlebology. 2013 Sep;28(6):320-3.

     

  153. Selles Dechent R, Arenas Ricart J, Ballester Ibáñez C, Pérez Monreal J, González Vila S, Ruiz del Castillo J.[Phlebectomies or foam sclerosis for treatment of the distal venous segment in the 3-S saphenectomy technique].Cir Esp. 2008 Aug;84(2):92-9. Spanish.

     

  154. Sellitti A, Furino E, Di Filippo A, Nasto A, Sellitti ME, Apperti M, Quarto G.Surgical crossectomy and saphenic trunk sclerotherapy. Preliminary results of a combined approach to the treatment of saphenous vein varices.Ann Ital Chir. 2018; 89:320-323.

     

  155. Shadid N, Nelemans P, Lawson J, Sommer A.Predictors of recurrence of great saphenous vein reflux following treatment with ultrasound-guided foamsclerotherapy.Phlebology. 2015 Apr;30(3):194-9.

     

  156. Shadid NH, van der Velden SK, van Oerle R, Ten Cate H, Sommer A, Nelemans P.In vivo effects of foam sclerotherapy on coagulation.Phlebology. 2014 Jun;29(5):287-92.

     

  157. Shepherd AC, Gohel MS, Lim CS, Hamish M, Davies AH.The treatment of varicose veins: an investigation of patient preferences and expectations.Phlebology. 2010 Apr;25(2):54-65.

     

  158. Smith PC.Chronic venous disease treated by ultrasound guided foam sclerotherapy.Eur J Vasc Endovasc Surg. 2006 Nov;32(5):577-83. Epub 2006 Jun 19.

     

  159. Stücker M, Reich S, Hermes N, Altmeyer P.Safety and efficiency of perilesional sclerotherapy in leg ulcer patients with postthrombotic syndrome and/or oral anticoagulation with phenprocoumon.J Dtsch Dermatol Ges. 2006 Sep;4(9):734-8.

     

  160. Stimpson P, Hewitt R, Barnacle A, Roebuck DJ, Hartley B.Sodium tetradecyl sulphate sclerotherapy for treating venous malformations of the oral and pharyngeal regions in children.Int J Pediatr Otorhinolaryngol. 2012 Apr;76(4):569-73. doi: 10.1016/j.ijporl.2012.01.019. Epub 2012 Feb 14. PubMed PMID: 22341629.

     

  161. Sun Y, Gu H, Yang X, Cai R, Shang Y, Hu L, Wang Y, Chen H, Lin X.Bleomycin Polidocanol Foam (BPF) Stability РIn Vitro Evidence for the Effectiveness of a Novel Sclerosant for Venous Malformations.Eur J Vasc Endovasc Surg. 2020

     

  162. Sun Y, Li X, Chen Z, Li X, Ren S.Feasibility and safety of foam sclerotherapy followed by a multiple subcutaneously interrupt ligation under local anaesthesia for outpatients with varicose veins.Int J Surg. 2017 Jun;42:49-53.

     

  163. Sylvoz N, Villier C, Blaise S, Seinturier C, Mallaret M.[Polidocanol induced cardiotoxicity: a case report and review of the literature].J Mal Vasc. 2008 Dec;33(4-5):234-8.

     

  164. Tan MKH, Salim S, Onida S, Davies AH.Postsclerotherapy compression: A systematic review.J Vasc Surg Venous Lymphat Disord. 2020 Aug 10. pii: S2213-333X(20)30432-7.

     

  165. Tan VK, Tan SG.Technique and early results of ultrasound-guided foam sclerotherapy of the long saphenous vein for treatment of varicose veins.Singapore Med J. 2009 Mar;50(3):284-7.

     

  166. Teruya TH, Ballard JL.New approaches for the treatment of varicose veins.Surg Clin North Am. 2004 Oct;84(5):1397-417, viii-ix. Review.

     

  167. Tessari L, Cavezzi A, Frullini A.Preliminary experience with a new sclerosing foam in the treatment of varicose veins.Dermatol Surg. 2001 Jan;27(1):58-60.

     

  168. Thomasset SC, Butt Z, Liptrot S, Fairbrother BJ, Makhdoomi KR.Ultrasound guided foam sclerotherapy: factors associated with outcomes and complications.Eur J Vasc Endovasc Surg. 2010 Sep;40(3):389-92.

     

  169. Toniolo J, Chiang N, Munteanu D, Russell A, Hao H, Chuen J.Vein diameter is a predictive factor for recanalization in treatment with ultrasound-guided foam sclerotherapy.J Vasc Surg Venous Lymphat Disord. 2018 Nov;6(6):707-716.

     

  170. remaine AM, Friedmann DP, Goldman MP.Foam sclerotherapy for reticular veins of the dorsal hands: a retrospective review.Dermatol Surg. 2014 Aug;40(8):892-8.

     

  171. Van den Bos R, Arends L, Kockaert M, Neumann M, Nijsten T.Endovenou therapies of lower extremity varicosities: a meta-analysis.J Vasc Surg. 2009 Jan;49(1):230-9. doi: 10.1016/j.jvs.2008.06.030. Epub 2008 Aug 9. Review.

     

  172. Van den Bremer J, Moll FL.Historical overview of varicose vein surgery.Ann Vasc Surg. 2010 Apr;24(3):426-32. doi: 10.1016/j.avsg.2009.07.035.

     

  173. Wang L, Liu F, Huang S.Percutaneous Lauromacrogol Foam Sclerotherapy for the Treatment of Acute Airway Compression Caused by Lymphatic Malformations in Infants.Biomed Res Int. 2018 Oct 18; 2018:3878960.

     

  174. Williamsson C, Danielsson P, Smith L.Catheter-directed foam sclerotherapy for chronic venous leg ulcers.Phlebology. 2014 Dec;29(10):688-93.

     

  175. Williamsson C, Danielsson P, Smith L.Catheter-directed foam sclerotherapy for insufficiency of the great saphenous vein: occlusion rates and patient satisfaction after one year.Phlebology. 2013 Mar;28(2):80-5.

     

  176. Wollmann JC.The history of sclerosing foams.Dermatol Surg. 2004 May;30(5):694-703; discussion 703. a Erratum in: Dermatol Surg. 2005 Feb;31(2):249.

     

  177. Yamaki T, Konoeda H, Fujisawa D, Ogino K, Osada A, Hamahata A, Nozaki M, Sakurai H.Changes in calf muscle deoxygenation after foam sclerotherapy in patients with superficial venous insufficiency.J Vasc Surg. 2012 Dec;56(6):1649-55.

     

  178. Yamaki T, Nozaki M, Fujiwara O, Yoshida E.Duplex-guided foam sclerotherapy for the treatment of the symptomatic venous malformations of the face.Dermatol Surg. 2002 Jul;28(7):619-22. PubMed PMID: 12135522.

     

  179. Yamaki T, Sasaki Y, Hasegawa Y, Osada A, Konoeda H, Hamahata A, Nozaki M, Sakurai H.Percutaneous ultrasound-guided sclerotherapy with polidocanol microfoam for lymphatic malformations.J Vasc Surg Venous Lymphat Disord. 2017 Sep;5(5):707-714. doi: 10.1016/j.jvsv.2017.03.017. Epub 2017 May 31.

     

  180. Yang B, Zhao J, Gao L, Li CL, Liu XR, Jiao H, Liao ZY, Yi C.CT-Guided Percutaneous Sclerotherapy for Low-Flow Retrobulbar Intraconal Venous Malformations.Cardiovasc Intervent Radiol. 2018 Mar;41(3):496-501.

     

  181. Yang X, Chen H, Gu H, Jin Y, Hu L, Hua C, Wang Y, Sun Y, Yu W, Lin X.Interim results of bleomycin-polidocanol foam sclerotherapy as a highly efficient technique for venous malformations.J Vasc Surg Venous Lymphat Disord. 2020 Nov;8(6):1066-1073.

     

  182. Yilmaz S, Ceken K, Alparslan A, Durmaz S, Sindel T.Endovenous laser ablation and concomitant foam sclerotherapy: experience in 504 patients.Cardiovasc Intervent Radiol. 2012 Dec;35(6):1403-7.

     

  183. Yin H, He H, Wang M, Li Z, Hu Z, Yao C, Wang J, Wang S, Chang G.Prospective Randomized Study of Ultrasound-Guided Foam Sclerotherapy Combined with Great Saphenous Vein High Ligation in the Treatment of Severe Lower Extremity Varicosis.Ann Vasc Surg. 2017 Feb;39:256-263.

     

  184. Zhu Y, Wu D, Sun D, Song K, Li J, Lin J.Ultrasound- and fluoroscopy-guided foam sclerotherapy for lower extremity venous ulcers.J Vasc Surg Venous Lymphat Disord. 2020 Sep;8(5):783-788.

     

  1. Belramman A, Bootun R, Lane TRA, Davies AH.Foam sclerotherapy versus ambulatory phlebectomy for the treatment of varicose vein tributaries: study protocol for a randomised controlled trial.Trials. 2019 Jul 3;20(1):392.

     

  2. Biemans AA, Kockaert M, Akkersdijk GP, van den Bos RR, de Maeseneer MG, Cuypers P, Stijnen T, Neumann MH, Nijsten T.Comparing endovenous laser ablation, foam sclerotherapy, and conventional surgery for great saphenous varicose veins.J Vasc Surg. 2013 Sep;58(3):727-34.e1.

     

  3. Bountouroglou DG, Azzam M, Kakkos SK, Pathmarajah M, Young P, Geroulakos G.Ultrasound-guided foam sclerotherapy combined with sapheno-femoral ligation compared to surgical treatment of varicose veins: early results of a randomized controlled trial.Eur J Vasc Endovasc Surg. 2006 Jan;31(1):93-100. Epub 2005 Oct 17.

     

  4. Brittenden J, Cotton SC, Elders A, Ramsay CR, Norrie J, Burr J, Campbell B, Bachoo P, Chetter I, Gough M, Earnshaw J, Lees T, Scott J, Baker SA, Francis J, Tassie E, Scotland G, Wileman S, Campbell MK.A randomized trial comparing treatments for varicose veins.N Engl J Med. 2014 Sep 25;371(13):1218-27.

     

  5. Brittenden J, Cotton SC, Elders A, Tassie E, Scotland G, Ramsay CR, Norrie J, Burr J, Francis J, Wileman S, Campbell B, Bachoo P, Chetter I, Gough M, Earnshaw J, Lees T, Scott J, Baker SA, MacLennan G, Prior M, Bolsover D, Campbell MK.Clinical effectiveness and cost-effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial.Health Technol Assess. 2015 Apr;19(27):1-342.

     

  6. Brown K, Moore CJ.Update on the treatment of saphenous reflux: laser, RFA or foam?Perspect Vasc Surg Endovasc Ther. 2009 Dec;21(4):226-31.

     

  7. Burihan MC.Endovenous ablation (radiofrequency and laser) and foam sclerotherapy versus conventional surgery for great saphenous vein varices.Sao Paulo Med J. 2014;132(1):69.

     

  8. Camillo O.Is catheter-directed foam sclerotherapy more effective than the usual foam sclerotherapy for treatment of the great saphenous vein?Phlebology. 2018 Oct;33(9):646-652.

     

  9. Campos W Jr, Torres IO, da Silva ES, Casella IB, Puech-Le√£o P.A prospective randomized study comparing polidocanol foam sclerotherapy with surgical treatment of patients with primary chronic venous insufficiency and ulcer.Ann Vasc Surg. 2015 Aug;29(6):1128-35.

     

  10. Carugo D, Ankrett DN, Zhao X, Zhang X, Hill M, O’Byrne V, Hoad J, Arif M, Wright DD, Lewis AL.Benefits of polidocanol endovenous microfoam (Varithena¬Æ) compared with physician-compounded foams.Phlebology. 2016 May;31(4):283-95.

     

  11. Ceulen RP, Bullens-Goessens YI, Pi-VAN DE Venne SJ, Nelemans PJ, Veraart JC, Sommer A.Outcomes and side effects of duplex-guided sclerotherapy in the treatment of great saphenous veins with 1% versus 3% polidocanol foam: results of a randomized controlled trial with 1-year follow-up.Dermatol Surg. 2007 Mar;33(3):276-81.

     

  12. Daniels JP, Champaneria R, Shah L, Gupta JK, Birch J, Moss JG.Effectiveness of Embolization or Sclerotherapy of Pelvic Veins for Reducing Chronic Pelvic Pain: A Systematic Review.J Vasc Interv Radiol. 2016 Oct;27(10):1478-1486.e8. doi: 10.1016/j.jvir.2016.04.016. Epub 2016 Jul 7. Review.

     

  13. Davies HO, Popplewell M, Darvall K, Bate G, Bradbury AW.A review of randomised controlled trials comparing ultrasound-guided foam sclerotherapy with endothermal ablation for the treatment of great saphenous varicose veins.Phlebology. 2016 May;31(4):234-40.

     

  14. Figueiredo M, Ara√∫jo S, Barros N Jr, Miranda F Jr.Results of surgical treatment compared with ultrasound-guided foam sclerotherapy in patients with varicose veins: a prospective randomised study.Eur J Vasc Endovasc Surg. 2009 Dec;38(6):758-63

     

  15. Friedmann DP, Liolios AM, Wu DC, Goldman MP, Eimpunth S. A Randomized, Double-Blind,Placebo-Controlled Study of the Effect of a High-Potency Topical Corticosteroid After Sclerotherapy for Reticular and Telangiectatic Veins of the Lower Extremities.Dermatol Surg. 2015 Oct;41(10):1158-63.

     

  16. Gillet JL, Desnos CH, Lausecker M, Daniel C, Guex JJ, Allaert FA.Sclerotherapy is a safe method of treatment of chronic venous disorders in older patients: A prospective and comparative study of consecutive patients.Phlebology. 2017 May;32(4):234-240.

     

  17. Gohel MS, Heatley F, Liu X, Bradbury A, Bulbulia R, Cullum N, Epstein DM, Nyamekye I, Poskitt KR, Renton S, Warwick J, Davies AH.Early versus deferred endovenous ablation of superficial venous reflux in patients with venous ulceration: the EVRA RCT.Health Technol Assess. 2019 May;23(24):1-96.

     

  18. Hamel-Desnos C, Desnos P, Wollmann JC, Ouvry P, Mako S, Allaert FA.Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results.Dermatol Surg. 2003 Dec;29(12):1170-5; discussion 1175.

     

  19. Hamel-Desnos C, Ouvry P, Benigni JP, Boitelle G, Schadeck M, Desnos P, Allaert FA.Comparison of 1% and 3% polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: a randomised, double-blind trial with 2 year-follow-up. «The 3/1 Study».Eur J Vasc Endovasc Surg. 2007 Dec;34(6):723-9; discussion 730. Epub 2007 Sep 20.

     

  20. Hamel-Desnos CM, Guias BJ, Desnos PR, Mesgard A.Foam sclerotherapy of the saphenous veins: randomised controlled trial with or without compression.Eur J Vasc Endovasc Surg. 2010 Apr;39(4):500-7.

     

  21. Kalodiki E, Lattimer CR, Azzam M, Shawish E, Bountouroglou D, Geroulakos G.Long-term results of a randomized controlled trial on ultrasound-guided foam sclerotherapy combined with saphenofemoral ligation vs standard surgery for varicose veins.J Vasc Surg. 2012 Feb;55(2):451-7.

     

  22. Kern P, Ramelet AA, Wutschert R, Bounameaux H, Hayoz D.Single-blind, randomized study comparing chromated glycerin, polidocanol solution, and polidocanol foam for treatment of telangiectatic leg veins.Dermatol Surg. 2004 Mar;30(3):367-72; discussion 372.

     

  23. Kishore R, Sankar TB, Anandi A, Nedunchezhian S, Murugan V.A Prospective Study in Comparison of Ambulatory Phlebectomy and Duplex Guided Foam Sclerotherapy in the Management of Varicosities with Isolated Perforator Incompetence.Indian J Surg. 2016 Oct;78(5):356-363.

     

  24. Lam YL, Lawson JA, Toonder IM, Shadid NH, Sommer A, Veenstra M, van der Kleij AMJ, Ceulen RP, de Haan E, Ibrahim F, van Dooren T, Nieman FH, Wittens CHA.Eight-year follow-up of a randomized clinical trial comparing ultrasound-guided foam sclerotherapy with surgical stripping of the great saphenous vein.Br J Surg. 2018 May;105(6):692-698.

     

  25. Lattimer CR, Azzam M, Kalodiki E, Shawish E, Trueman P, Geroulakos G.Cost and effectiveness of laser with phlebectomies compared with foam sclerotherapy in superficial venous insufficiency. Early results of a randomised controlled trial.Eur J Vasc Endovasc Surg. 2012 May;43(5):594-600.

     

  26. Lattimer CR, Kalodiki E, Azzam M, Makris GC, Somiayajulu S, Geroulakos G.Interim results on abolishing reflux alongside a randomized clinical trial on laser ablation with phlebectomies versus foam sclerotherapy.Int Angiol. 2013 Aug;32(4):394-403..

     

  27. Lawaetz M, Serup J, Lawaetz B, Bjoern L, Blemings A, Eklof B, Rasmussen L.Comparison of endovenous ablation techniques, foam sclerotherapy and surgical stripping for great saphenous varicose veins. Extended 5-year follow-up of a RCT.Int Angiol. 2017 Jun;36(3):281-288.

     

  28. Li X, Yang B, Li X, Ren S.Prospective Comparison of Effect of Ligation and Foam Sclerotherapy with Foam Sclerotherapy Alone for Varicose Veins.Ann Vasc Surg. 2018 May; 49:75-79.

     

  29. Liu X, Jia X, Guo W, Xiong J, Zhang H, Liu M, Du X, Zhang M.Ultrasound-guided foam sclerotherapy of the great saphenous vein with sapheno-femoral ligation compared to standard stripping: a prospective clinical study.Int Angiol. 2011 Aug;30(4):321-6.

     

  30. Marsden G, Perry M, Bradbury A, Hickey N, Kelley K, Trender H, Wonderling D, Davies AH.A Cost-effectiveness Analysis of Surgery, Endothermal Ablation, Ultrasound-guided Foam Sclerotherapy and Compression Stockings for Symptomatic Varicose Veins.Eur J Vasc Endovasc Surg. 2015 Dec;50(6):794-801.

     

  31. McAree B, Ikponmwosa A, Brockbank K, Abbott C, Homer-Vanniasinkam S, Gough MJ.Comparative stability of sodium tetradecyl sulphate (STD) and polidocanol foam: impact on vein damage in an in-vitro model.Eur J Vasc Endovasc Surg. 2012 Jun;43(6):721-5.

     

  32. Mishra MK, Soni RK, Mohil RS, Sinha A.Comparative Study of Outcome of Duplex Ultrasound-Guided, Catheter-Directed Foam Sclerotherapy and Radio-frequency Ablation in the Management of Great Saphenous Varicose Veins.Indian J Surg. 2016 Oct;78(5):375-381.

     

  33. Moser KH, Mosch C, Walgenbach M, Bussen DG, Kirsch J, Joos AK, Gliem P, Sauerland S.Efficacy and safety of sclerotherapy with polidocanol foam in comparison with fluid sclerosant in the treatment of first-grade haemorrhoidal disease: a randomised, controlled, single-blind, multicentre trial.Int J Colorectal Dis. 2013 Oct;28(10):1439-47.

     

  34. O’Hare JL, Earnshaw JJ.Randomised clinical trial of foam sclerotherapy for patients with a venous leg ulcer.Eur J Vasc Endovasc Surg. 2010 Apr;39(4):495-9.

     

  35. Ouvry P, Allaert FA, Desnos P, Hamel-Desnos C.Efficacy of polidocanol foam versus liquid in sclerotherapy of the great saphenous vein: a multicenter randomised controlled trial with a 2-year follow-up.Eur J Vasc Endovasc Surg. 2008 Sep;36(3):366-70. doi: 10.1016/j.ejvs.2008.04.010. Epub 2008 Jun 3.

     

  36. Parlar B, Blazek C, Cazzaniga S, Naldi L, Kloetgen HW, Borradori L, Buettiker U.Treatment of lower extremity telangiectasias in women by foam sclerotherapy vs. Nd:YAG laser: a prospective, comparative, randomized, open-label trial.J Eur Acad Dermatol Venereol. 2015 Mar;29(3):549-54.

     

  37. Rai A, Porsalman M, Khatony A, Sobhiyeh M.Comparison of foam sclerotherapy versus radiofrequency ablation in the treatment of primary varicose veins due to incompetent great saphenous vein: Randomized clinical trial.J Vasc Nurs. 2019 Dec;37(4):226-231.

     

  38. Ran F, Shi Y, Qiao T, Shang T, Liu Z, Liu CJ.Comparison of Foam Sclerotherapy Alone or Combined With Stripping of the Great Saphenous Vein for Treating Varicose Veins.Dermatol Surg. 2017 Apr;43(4):541-547.

     

  39. Rao J, Wildemore JK, Goldman MP.Double-blind prospective comparative trial between foamed and liquid polidocanol and sodium tetradecyl sulfate in the treatment of varicose and telangiectatic leg veins.Dermatol Surg. 2005 Jun;31(6):631-5; discussion 635.

     

  40. Rasmussen L, Lawaetz M, Serup J, Bjoern L, Vennits B, Blemings A, Eklof B.Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy, and surgical stripping for great saphenous varicose veins with 3-year follow-up.J Vasc Surg Venous Lymphat Disord. 2013 Oct;1(4):349-56.

     

  41. Rasmussen LH, Lawaetz M, Bjoern L, Vennits B, Blemings A, Eklof B.Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins.Br J Surg. 2011 Aug;98(8):1079-87.

     

  42. Shadid N, Ceulen R, Nelemans P, Dirksen C, Veraart J, Schurink GW, van Neer P, vd Kley J, de Haan E, Sommer A.Randomized clinical trial of ultrasound-guided foam sclerotherapy versus surgery for the incompetent great saphenous vein.Br J Surg. 2012 Aug;99(8):1062-70.

     

  43. Shadid N, Ceulen R, Nelemans P, Dirksen C, Veraart J, Schurink GW, van Neer P, vd Kley J, de Haan E, Sommer A.Randomized clinical trial of ultrasound-guided foam sclerotherapy versus surgery for the incompetent great saphenous vein.Br J Surg. 2012 Aug;99(8):1062-70.

     

  44. Siribumrungwong B, Noorit P, Wilasrusmee C, Leelahavarong P, Thakkinstian A, Teerawattananon Y.Cost-utility analysis of great saphenous vein ablation with radiofrequency, foam and surgery in the emerging health-care setting of Thailand.Phlebology. 2016 Sep;31(8):573-81.

     

  45. Tassie E, Scotland G, Brittenden J, Cotton SC, Elders A, Campbell MK, Campbell B, Gough M, Burr JM, Ramsay CR;CLASS study team. Cost-effectiveness of ultrasound-guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial.Br J Surg. 2014 nov;101(12):1532-40.

     

  46. Ukritmanoroat T.Comparison of efficacy and safety between foam sclerotherapy and conventional sclerotherapy: a controlled clinical trial.J Med Assoc Thai. 2011 Mar;94 Suppl 2:S35-40.

     

  47. Uncu H.Sclerotherapy: a study comparing polidocanol in foam and liquid form.Phlebology. 2010 Feb;25(1):44-9.

     

  48. Vähäaho S, Halmesmäki K, Albäck A, Saarinen E, Venermo M.Five-year follow-up of a randomized clinical trial comparing open surgery, foam sclerotherapy and endovenous laser ablation for great saphenous varicose veins.Br J Surg. 2018 May;105(6):686-691.

     

  49. Van der Velden SK, Biemans AA, De Maeseneer MG, Kockaert MA, Cuypers PW, Hollestein LM, Neumann HA, Nijsten T, van den Bos RR.Five-year results of randomized clinical trial of conventional surgery, endovenous laser ablation and ultrasound-guided foam sclerotherapy in patients with great saphenous varicose veins.Br J Surg. 2015 Sep;102(10):1184-94.

     

  50. Venermo M, Saarinen J, Eskelinen E, Vähäaho S, Saarinen E, Railo M, Uurto I, Salenius J, Albäck A;Finnish Venous Study Collaborators. Randomized clinical trial comparing surgery, endovenous laser ablation and ultrasound-guided foam sclerotherapy for the treatment of great saphenous varicose veins.Br J Surg. 2016 Oct;103(11):1438-44.

     

  51. Wang JC, Li Y, Li GY, Xiao Y, Li WM, Ma Q, Liu JL, Lu SY.A Comparison of Concomitant Tributary Laser Ablation and Foam Sclerotherapy in Patients Undergoing Truncal Endovenous Laser Ablation for Lower Limb Varicose Veins.J Vasc Interv Radiol. 2018 Jun;29(6):781-789.

     

  52. Yamaki T, Hamahata A, Soejima K, Kono T, Nozaki M, Sakurai H.Prospective randomised comparative study of visual foam sclerotherapy alone or in combination with ultrasound-guided foam sclerotherapy for treatment of superficial venous insufficiency: preliminary report.Eur J Vasc Endovasc Surg. 2012 Mar;43(3):343-7.

     

  53. Yamaki T, Nozaki M, Iwasaka S.Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of superficial venous insufficiency.Dermatol Surg. 2004 May;30(5):718-22; discussion 722.

     

  54. Yamaki T, Nozaki M, Sakurai H, Takeuchi M, Soejima K, Kono T.Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations.J Vasc Surg. 2008 Mar;47(3):578-84.

     

  55. Zhao ZY, Zhang XJ, Li JH, Huang M.Comparison of high ligation and stripping of the great saphenous vein combined with foam sclerotherapy versus conventiona surgery for the treatment of superficial venous varicosities of the lower extremity.Int J Clin Exp Med. 2015 May 15;8(5):7843-8.

     

  1. Atasoy MM.Fill and aspirate foam sclerotherapy (FAFS): a new approach for sclerotherapy of large superficial varicosities concomitant to endovenous laser ablation of truncal vein.Clin Radiol. 2015 Jan;70(1):48-53.

     

  2. Bai T, Chen Y, Jiang W, Yan F, Fan Y.Studies on Foam Decay Trend and Influence of Temperature Jump on Foam Stability in Sclerotherapy.Vasc Endovascular Surg. 2018 Feb;52(2):98-106.

     

  3. Bai T, Jiang W, Chen Y, Yan F, Xu Z, Fan Y.Effect of Multiple Factors on Foam Stability in Foam Sclerotherapy.Sci Rep. 2018 Oct 24;8(1):15683.

     

  4. Bai T, Jiang W, Fan Y.Influence of Syringe Volume on Foam Stability in Sclerotherapy for Varicose Vein Treatment.Dermatol Surg. 2018 May;44(5):689-696.

     

  5. Bai T, Liu Y, Liu J, Yu C, Jiang W, Fan Y.A comparison of different surfactants on foam stability in foam sclerotherapy in vitro.J Vasc Surg. 2019 Feb;69(2):581-591.e1.

     

  6. Bai T, Taoping PhD*; Liu, Yuqiu BS*; Jiang, Wentao PhD*; Li, Yalan PhD*; Liu, Jiche BS*; Yu, Chenhao BS†; Fan, Yubo PhD‡A Review of Sclerosing Foam Stability in the Treatment of Varicose Veins.Dermatologic Surgery: February 2020 – Volume 46 – Issue 2 – p 249-257

     

  7. Bi M, Li D, Chen Z, Wang Y, Ren J, Zhang W.Foam sclerotherapy compared with liquid sclerotherapy for the treatment of lower extremity varicose veins: A protocol for systematic review and meta-analysis.Medicine (Baltimore). 2020 May 9;99(22): e20332.

     

  8. Bidwai A, Beresford T, Dialynas M, Prionidis J, Panayiotopoulos Y, Browne TF.Balloon control of the saphenofemoral junction during foam sclerotherapy: proposed innovation.J Vasc Surg. 2007 Jul;46(1):145-7.

     

  9. Bottaro E, Paterson J, Zhang X, Hill M, Patel VA, Jones SA, Lewis AL, Millar TM, Carugo D.Physical Vein Models to Quantify the Flow Performance of Sclerosing Foams.Front Bioeng Biotechnol. 2019 May 21;7:109.

     

  10. Chen AW, Liu YR, Li K, Liu SH.An Investigation on the Influence of Hyaluronic Acid on Polidocanol Foam Stability.Dermatol Surg. 2016 Jan;42(1):56-8.

     

  11. Cilurzo F, Critello CD, Paolino D, Fiorillo AS, Fresta M, De Franciscis S, Celia C.Polydocanol foam stabilized by liposomes: Supramolecular nanoconstructs for sclerotherapy.Colloids Surf B Biointerfaces. 2019 Mar 1; 175:469-476.

     

  12. Critello CD, Fiorillo AS, Matula TJ.Size of Sclerosing Foams Prepared by Ultrasound, Mechanical Agitation, and the Handmade Tessari Method for Treatment of Varicose Veins.J Ultrasound Med. 2017 Mar;36(3):649-658.

     

  13. Critello CD, Pullano SA, Matula TJ, De Franciscis S, Serra R, Fiorillo AS.Recent developments on foaming mechanical and electronic techniques for the management of varicose veins.Expert Rev Med Devices. 2019 Nov;16(11):931-940.

     

  14. Erkin A, Kosemehmetoglu K, Diler MS, Koksal C.Evaluation of the minimum effective concentration of foam sclerosant in an ex-vivo study.Eur J Vasc Endovasc Surg. 2012 Dec;44(6):593-7.

     

  15. Gonzalez-Zeh R, Armisen R, Barahona S.Endovenous laser and echo-guided foam ablation in great saphenous vein reflux: one-year follow-up results.J Vasc Surg. 2008 Oct;48(4):940-6.

     

  16. Hanshu Z, Shaohua L, Anwei C.A Novel Compound Sclerosant: Polidocanol-Bleomycin Foam.Dermatol Surg. 2020 Aug 5.

     

  17. Hashimoto K, Uchida B, Horikawa M, Mimura H, Farsad K.Effects of Different Mixing Agents on the Stability of Sodium Tetradecyl Sulfate (STS) Foam: An Experimental Study.Cardiovasc Intervent Radiol. 2018 Dec;41(12):1952-1957.

     

  18. Hill D, Hamilton R, Fung T.Assessment of techniques to reduce sclerosant foam migration during ultrasound-guided sclerotherapy of the great saphenous vein.J Vasc Surg. 2008 Oct;48(4):934-9.

     

  19. Iannitti T, Rottigni V, Torricelli F, Palmieri B.Combination therapy of hyaluronic acid mesotherapic injections and sclerotherapy for treatment of lower leg telangiectasia without major venous insufficiency: a preliminary clinical study.Clin Appl Thromb Hemost. 2014 Apr;20(3):326-30.

     

  20. Ikponmwosa A, Abbott C, Graham A, Homer-Vanniasinkam S, Gough MJ.The impact of different concentrations of sodium tetradecyl sulphate and initial balloon denudation on endothelial cell loss and tunica media injury in a model of foam sclerotherapy.Eur J Vasc Endovasc Surg. 2010 Mar;39(3):366-71.

     

  21. Kaygin MA, Halici U.Evaluation of liquid or foam sclerotherapy in small varicose veins (ceap c1) with venous clinical severity score.Rev Assoc Med Bras (1992). 2018 Dec;64(12):1117-1121.

     

  22. Kayssi A, Oreopoulos G, Tan KT, Jaskolka J.Combined Coil Embolization and Foam Sclerotherapy for the Management of Varicose Veins.Ann Vasc Surg. 2017 Jan; 38:293-297.

     

  23. Lai SW, Goldman MP.Does the relative silicone content of different syringes affect the stability of foam in sclerotherapy?J Drugs Dermatol. 2008 Apr;7(4):399-400.

     

  24. Li K, Liu YR, Chen AW, Liu SH.A new method for using radiopaque sclerosing foam to treat venous malformations.Dermatol Surg. 2015 Jun;41(6):726-30.

     

  25. Lim SY, Tan JX, D’Cruz RT, Syn N, Chong TT, Tang TY.Catheter-directed foam sclerotherapy, an alternative to ultrasound-guided foam sclerotherapy for varicose vein treatment: A systematic review and meta-analysis.Phlebology. 2020 Jul;35(6):369-383.

     

  26. Lucio Filho CEP, Bertanha M, Prata MP, Carvalho LR, Jaldin RG, Sobreira ML, Janzen J, Yoshida WB.Efficacy and safety of glucose, glucose and polidocanol combination, liquid polidocanol and polidocanol foam in the treatment of reticular veins: A randomized study in rabbits.Phlebology. 2020 Oct 8:268355520964293.

     

  27. Meghdadi A, Jones SA, Patel VA, Lewis AL, Millar TM, Carugo D.Foam-in-vein: A review of rheological properties and characterization methods for optimization of sclerosing foams.J Biomed Mater Res B Appl Biomater. 2020 Jul 4.

     

  28. Nastasa V, Samaras K, Ampatzidis Ch, Karapantsios TD, Trelles MA, Moreno-Moraga J, Smarandache A, Pascu ML.Properties of polidocanol foam in view of its use in sclerotherapy.Int J Pharm. 2015 Jan 30;478(2):588-96.

     

  29. Park SW, Yun IJ, Hwang JJ, Lee SA, Kim JS, Chee HK, Chang IS.Fluoroscopy-guided endovenous sclerotherapy using a microcatheter prior to endovenous laser ablation: comparison between liquid and foam sclerotherapy for varicose tributaries.Korean J Radiol. 2014 Jul-Aug;15(4):481-7.

     

  30. Patel SB, Ostler AE, Dos Santos SJ, Piriea TM, Whiteley MS.The effects of environmental and compositional manipulations on the longevity of Tessari-made foam for sclerotherapy.J Vasc Surg Venous Lymphat Disord. 2015 Jul;3(3):312-8.

     

  31. Peterson JD, Goldman MP.An investigation into the influence of various gases and concentrations of sclerosants on foam stability.Dermatol Surg. 2011 Jan;37(1):12-7.

     

  32. Peterson JD, Goldman MP.An investigation on the influence of glycerin on sclerosant foam stability.Phlebology. 2011 Sep;26(6):232-4.

     

  33. Pihlaja T, Romsi P, Ohtonen P, Jounila J, Pokela M.Post-procedural Compression vs. No Compression After Radiofrequency Ablation and Concomitant Foam Sclerotherapy of Varicose Veins: A Randomised Controlled Non-Inferiority Trial.Eur J Vasc Endovasc Surg. 2020 Jan;59(1):73-80.

     

  34. Rao J, Goldman MP.Stability of foam in sclerotherapy: differences between sodium tetradecyl sulfate and polidocanol and the type of connector used in the double-syringe system technique.Dermatol Surg. 2005 Jan;31(1):19-22.

     

  35. Rial R, Hervas LS, Monux G, Galindo A, Martin A, Hernando M, Martinez I, Hernando A, Serrano FJ.Polidocanol foam stability in terms of its association with glycerin.Phlebology. 2014 Jun;29(5):304-9.

     

  36. Roche E, Pons R, Roche O, Puig A.A new automated system for the preparation of sclerosant foam: A study of the physical characteristics produced and the device settings required.Phlebology. 2020 Oct;35(9):724-733.

     

  37. 37. Star P, Connor DE, Parsi K.Novel developments in foam sclerotherapy: Focus on Varithena® (polidocanol endovenous microfoam) in the management of varicose veins.Phlebology. 2018 Apr;33(3):150-162.

     

  38. Tan L, Wong K, Connor D, Fakhim B, Behnia M, Parsi K.Generation of sclerosant foams by mechanical methods increases the foam temperature.Phlebology. 2017 Aug;32(7):501-505.

     

  39. VAN Deurzen B, Ceulen RP, Tellings SS, VAN DER Geld C, Nijsten T.Polidocanol concentration and time affect the properties of foam used for sclerotherapy.Dermatol Surg. 2011 Oct;37(10):1448-55.

     

  40. Wan H, Bai T, Jiang W, Huang X, Zhao W.[Development of Automatic Preparation Device of Sclerosing Foam Based on Tessari Method].Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2016 Dec;33(6):1191-5. Chinese.

     

  41. Watkins MR, Oliver RJ.Physiochemical properties and reproducibility of air-based sodium tetradecyl sulphate foam using the Tessari method.Phlebology. 2017 Jul;32(6):390-396.

     

  42. Whiteley MS, Patel SB.Modified Tessari Tourbillon technique for making foam sclerotherapy with silicone-free syringes.Phlebology. 2015 Oct;30(9):614-7.

     

  43. Xu J, Wang YF, Chen AW, Wang T, Liu SH.A modified Tessari method for producing more foam.Springerplus. 2016 Feb 19; 5:129.

     

  44. Yamaki T, Nozaki M, Sakurai H, Takeuchi M, Soejima K, Kono T.Multiple small-dose injections can reduce the passage of sclerosant foam into deep veins during foam sclerotherapy for varicose veins.Eur J Vasc Endovasc Surg. 2009 Mar;37(3):343-8.

     

  45. Zhang H, Song YT, Zhang HS, Zhang F, Liu SH.Effects of Hyaluronic Acid on Stability of Bleomycin Foam.Dermatol Surg. 2020 Sep;46(9):1171-1175.

     

  46. Zhang H, Yang A, Xu M, Liu S.A Modified 3-Way Tap to Enhance the Stability and Uniformity of Sclerosant Foam.Ann Vasc Surg. 2020 Sep 2. pii: S0890-5096(20)30797-4.

     

  47. Zhang H, Zhang HS, Chen AW, Zhang F, Liu SH.Modified Method to Increase the Volume and Stability of Bleomycin Foam: An Experimental Study.Dermatol Surg. 2020 Aug;46(8):1030-1034.

     

  48. Zhang HS, Yang AJ, Liu S.Identifying the Most Stable State of a Foam Sclerosant for Foam Sclerotherapy.Dermatol Surg. 2020 Oct;46(10):e66-e70.

     

  49. Zhang X, Wang X, Gao C, Qin J, Zhao H, Li W, Lu X.A 1470-nm laser combined with foam sclerotherapy in day surgery: a better choice for lower limb varicose veins.Lasers Med Sci. 2018 Sep;33(7):1505-1511. doi: 10.1007/s10103-018-2507-8. Epub 2018 Apr 23. PubMed PMID: 29687409.

     

  1. Abdelhamid N, Farooq S, Sarraj A.Acute Ischemic Stroke in a Young Woman With No Known Risk Factors.WMJ. 2018 Mar;117(1):42-44.

     

  2. Allevi F, Rabbiosi D, Mandalà M, Colletti G.Paradoxical embolism following intralesional sclerotherapy for cervical venous malformation.BMJ Case Rep. 2014 Nov 24;2014. pii: bcr2014206781.

     

  3. Asbjornsen CB, Rogers CD, Russell BL.Middle cerebral air embolism after foam sclerotherapy.Phlebology. 2012 Dec;27(8):430-3.

     

  4. Beckitt T, Elstone A, Ashley S.Air versus physiological gas for ultrasound guided foam sclerotherapy treatment of varicose veins.Eur J Vasc Endovasc Surg. 2011 Jul;42(1):115-9.

     

  5. Bhogal RH, Moffat CE, Coney P, Nyamekye IK.Can foam sclerotherapy be used to safely treat bilateral varicose veins?Phlebology. 2012 Feb;27(1):19-24.

     

  6. Bittencourt AH, Dallanora DV, Bacega NR, Cembranel VS.Cerebrovascular ischemia following ultrasound-guided foam sclerotherapy.J Vasc Bras. 2018 Oct-Dec;17(4):333-336.

     

  7. Bruijninckx CM.Fatal pulmonary embolism following ultrasound-guided foam sclerotherapy combined with multiple microphlebectomies. Phlebology. 2016 Chen J, Liu YR, Sun YD, Liu C, Zhuo SY, Li K, Wei FC, Liu SH. The risk of bacteria in foam sclerotherapy: does the condition of the air in outpatient vs. operating rooms make a difference?Br J Dermatol. 2014 Dec;171(6):1386-90.

     

  8. Bush RG, Derrick M, Manjoney D.Major neurological events following foam sclerotherapy.Phlebology. 2008;23(4):189-92.

     

  9. Ceulen RP, Jagtman EA, Sommer A, Teule GJ, Schurink GW, Kemerink GJ.Blocking the saphenofemoral junction during ultrasound-guided foam sclerotherapy– assessment of a presumed safety-measure procedure.Eur J Vasc Endovasc Surg. 2010 Dec;40(6):772-6.

     

  10. Coudray S, Aïchoun I, Ricci JE, Penne C, Schuster I, Pérez-Martin A.[Unusual consequences of foam sclerotherapy].J Mal Vasc. 2015 Feb;40(1):37-41.

     

  11. de Aguiar ET, Dos Santos JB, Carvalho DD.Venous thromboembolism after ultrasound guided foam sclerotherapy.Phlebology. 2020 Oct 6:268355520957202.

     

  12. de Franciscis S, Nobile C, Larosa E, Montemurro R, Serra R.Air contamination in the sclerosing foam for the treatment of varicose veins.Phlebology. 2016 Mar;31(2):96-100.

     

  13. de Roos KP, Groen L, Leenders AC.Foam sclerotherapy: investigating the need for sterile air.Dermatol Surg. 2011 Aug;37(8):1119-24

     

  14. Dermody M, Schul MW, O’Donnell TF.Thromboembolic complications of endovenous thermal ablation and foam sclerotherapy in the treatment of great saphenous vein insufficiency.Phlebology. 2015 Jun;30(5):357-64.

     

  15. Fabi SG, Peterson JD, Goldman MP, Guiha I.An investigation of coagulation cascade activation and induction of fibrinolysis using foam sclerotherapy of reticular veins.Dermatol Surg. 2012 Mar;38(3):367-72.

     

  16. Forlee MV, Grouden M, Moore DJ, Shanik G.Stroke after varicose vein foam injection sclerotherapy.J Vasc Surg. 2006 Jan;43(1):162-4.

     

  17. Frullini A, Barsotti MC, Santoni T, Duranti E, Burchielli S, Di Stefano R.Significant endothelin release in patients treated with foam sclerotherapy.Dermatol Surg. 2012 May;38(5):741-7.

     

  18. Frullini A, Da Pozzo E, Felice F, Burchielli S, Martini C, Di Stefano R.Prevention of excessive endothelin-1 release in sclerotherapy: in vitro and in vivo studies.Dermatol Surg. 2014 Jul;40(7):769-75.

     

  19. Frullini A, Felice F, Burchielli S, Di Stefano R.High production of endothelin after foam sclerotherapy: a new pathogenetic hypothesis for neurological and visual disturbances after sclerotherapy.Phlebology. 2011 Aug;26(5):203-8.

     

  20. Gillet JL, Donnet A, Lausecker M, Guedes JM, Guex JJ, Lehmann P.Pathophysiology of visual disturbances occurring after foam sclerotherapy.Phlebology. 2010 Oct;25(5):261-6.

     

  21. Gillet JL, Guedes JM, Guex JJ, Hamel-Desnos C, Schadeck M, Lauseker M, Allaert FA.Side-effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1,025 patients.Phlebology. 2009 Jun;24(3):131-8.

     

  22. Guex JJ, Allaert FA, Gillet JL, Chleir F.Immediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12,173 sclerotherapy sessions.Dermatol Surg. 2005 Feb;31(2):123-8; discussion 128.

     

  23. Guex JJ.Complications of sclerotherapy: an update.Dermatol Surg. 2010 Jun;36 Suppl 2:1056-1063. Review.

     

  24. Hahn M, Schulz T, Jünger M.Late stroke after foam sclerotherapy.Vasa. 2010 Feb;39(1):108-10.

     

  25. Hartmann K, Harms L, Simon M.Reversible neurological deficit after foam sclerotherapy.Eur J Vasc Endovasc Surg. 2009 Nov;38(5):648-9.

     

  26. Hill DA.Neurological and chest symptoms following sclerotherapy: a single centre experience.Phlebology. 2014 Oct;29(9):619-27.

     

  27. Hoss E, Kollipara R, Boen M, Alhaddad M, Goldman MP.Comparison of the Safety and Efficacy of Foam Sclerotherapy With 1: 2 Polidocanol to Air Ratio Versus 1: 4 Ratio for the Treatment of Reticular Veins of the Lower Extremities.Dermatol Surg. 2020 Sep 15.

     

  28. Kim M, Niroumandpour M, Poustinchian B.Transient Ischemic Attack After Foam Sclerotherapy in a Woman with a Patent Foramen Ovale.J Am Osteopath Assoc. 2016 May 1;116(5):320-3.

     

  29. Kulkarni SR, Messenger DE, Slim FJ, Emerson LG, Bulbulia RA, Whyman MR, Poskitt KR.The incidence and characterization of deep vein thrombosis following ultrasound-guided foam sclerotherapy in 1000 legs with superficial venous reflux.J Vasc Surg Venous Lymphat Disord. 2013 Jul;1(3):231-8.

     

  30. Lobastov K, Vorontsova A, Bargandzhiya A, Tsaplin S, Schastlivtsev I, Barinov V, Laberko L, Dvornikov A.The frequency and clinical significance of nontarget superficial and deep vein occlusion after physician compounded foam sclerotherapy of varicose tributaries.Phlebology. 2020 Jul;35(6):430-439.

     

  31. Malvehy MA, Asbjornsen C.Transient neurologic event following administration of foam sclerotherapy.Phlebology. 2017 Feb;32(1):66-68.

     

  32. Matsuzono K, Arai N, Suzuki M, Kim Y, Ozawa T, Mashiko T, Shimazaki H, Koide R, Matsuura T, Fujimoto S.Tissue Plasminogen Activator to Treat a Stroke after Foam Sclerotherapy in a Woman with a Patent Foramen Ovale.J Stroke Cerebrovasc Dis. 2018 Jun;27(6):e110-e112.

     

  33. Morrison N, Neuhardt DL, Rogers CR, McEown J, Morrison T, Johnson E, Salles-Cunha SX.Incidence of side effects using carbon dioxide-oxygen foam for chemical ablation of superficial veins of the lower extremity.Eur J Vasc Endovasc Surg. 2010 Sep;40(3):407-13.

     

  34. Morrison N, Neuhardt DL, Rogers CR, McEown J, Morrison T, Johnson E, Salles-Cunha SX.Comparisons of side effects using air and carbon dioxide foam for endovenous chemical ablation.J Vasc Surg. 2008 Apr;47(4):830-6.

     

  35. Morrison N, Neuhardt DL.Foam sclerotherapy: cardiac and cerebral monitoring.Phlebology. 2009 Dec;24(6):252-9. doi: 10.1258/phleb.2009.009051. Review. PubMed PMID: 19952381.

     

  36. Parsi K, Panozzo B, Bull A, Yang A, Kang M, Parsi Y, Connor DE.Deep vein sclerosis following sclerotherapy: Ultrasonic and d-dimer criteria.Phlebology. 2020 Jun;35(5):325-336.

     

  37. Parsi K.Paradoxical embolism, stroke and sclerotherapy.Phlebology. 2012 Jun;27(4):147-67. doi: 10.1258/phleb.2011.010098. Epub 2011 Sep 2. Review.

     

  38. Parsi K.Venous gas embolism during foam sclerotherapy of saphenous veins despite recommended treatment modifications.Phlebology. 2011 Jun;26(4):140-7.

     

  39. Peterson JD, Goldman MP.An investigation of side-effects and efficacy of foam-based sclerotherapy with carbon dioxide or room air in the treatment of reticular leg veins: a pilot study.Phlebology. 2012 Mar;27(2):73-6.

     

  40. Rastel D.Immediate and transient faintness following a course of foam sclerotherapy treatment for saphenous vein incompetence in an elderly patient.J Mal Vasc. 2016 Dec;41(6):412-415.

     

  41. Raymond-Martimbeau P.Transient adverse events positively associated with patent foramen ovale after ultrasound-guided foam sclerotherapy.Phlebology. 2009 Jun;24(3):114-9.

     

  42. Regan JD, Gibson KD, Rush JE, Shortell CK, Hirsch SA, Wright DD.Clinical significance of cerebrovascular gas emboli during polidocanol endovenous ultra-low nitrogen microfoam ablation and correlation with magnetic resonance imaging in patients with right-to-left shunt.J Vasc Surg. 2011 Jan;53(1):131-7.

     

  43. Sarvananthan T, Shepherd AC, Willenberg T, Davies AH.Neurological complications of sclerotherapy for varicose veins.J Vasc Surg. 2012 Jan;55(1):243-51.

     

  44. Schuller-Petrović S, Pavlović MD, Neuhold N, Brunner F, Wölkart G.Subcutaneous injection of liquid and foamed polidocanol: extravasation is not responsible for skin necrosis during reticular and spider vein sclerotherapy.J Eur Acad Dermatol Venereol. 2011 Aug;25(8):983-6.

     

  45. Star P, Choy C, Parsi K.Black veins: a case of minocycline-induced pigmentation post-sclerotherapy and a review of literature.J Cutan Pathol. 2017 Jan;44(1):83-92.

     

  46. Stephens R, Dunn S.Non-ST-elevation myocardial infarction following foam ultrasound-guided sclerotherapy.Phlebology. 2014 Aug;29(7):488-90.

     

  47. Whiteley MS, Smith VC.Exacerbation of alopecia areata: A possible complication of sodium tetradecyl sulphate foam sclerotherapy treatment for varicose veins.SAGE Open Med Case Rep. 2017 Jun 2; 5:2050313X17712643.

     

  48. Willenberg T, Smith PC, Shepherd A, Davies AH.Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review.Phlebology. 2013 Apr;28(3):123-31.

     

  49. Wong M.Should foam made with physiologic gases be the standard in sclerotherapy?Phlebology. 2015 Oct;30(9):580-6.

     

  1. Bai T, Liu Y, Jiang W, Li Y, Liu J, Yu C, Fan Y.A Review of Sclerosing Foam Stability in the Treatment of Varicose Veins.Dermatol Surg. 2020 Feb;46(2):249-257.

     

  2. Bergan J, Cheng V.Foam sclerotherapy for the treatment of varicose veins.Vascular. 2007 Sep-Oct;15(5):269-72. Review.

     

  3. Bergan JJ, Pascarella L.Severe chronic venous insufficiency: primary treatment with sclerofoam.Semin Vasc Surg. 2005 Mar;18(1):49-56. Review.

     

  4. Biemans AA, Van Den Bos RR, Nijsten T.Endovenous therapies of varicose veins: indications, procedures, efficacy and safety.G Ital Dermatol Venereol. 2010 Apr;145(2):161-73. Review.

     

  5. Boersma D, Kornmann VN, van Eekeren RR, Tromp E, Ünlü Ç, Reijnen MM, de Vries JP.Treatment Modalities for Small Saphenous Vein Insufficiency: Systematic Review and Meta-analysis.J Endovasc Ther. 2016 Feb;23(1):199-211.

     

  6. Breu FX, Guggenbichler S, Wollmann JC;Second European Consensus Meeting on Foam Sclerotherapy. Duplex ultrasound and efficacy criteria in foam sclerotherapy from the 2nd European Consensus Meeting on Foam Sclerotherapy 2006, Tegernsee, Germany.Vasa. 2008 Feb;37(1):90-5.

     

  7. Breu FX, Guggenbichler S, Wollmann JC.2nd European Consensus Meeting on Foam Sclerotherapy 2006, Tegernsee, Germany.Vasa. 2008 Feb;37 Suppl 71:1-29.

     

  8. Breu FX, Guggenbichler S.European Consensus Meeting on Foam Sclerotherapy, April, 4-6, 2003, Tegernsee, Germany.Dermatol Surg. 2004 May;30(5):709-17; discussion 717. Review.

     

  9. Bunke N, Brown K, Bergan J.Foam sclerotherapy: techniques and uses.Perspect Vasc Surg Endovasc Ther. 2009 Jun;21(2):91-3.

     

  10. Carroll C, Hummel S, Leaviss J, Ren S, Stevens JW, Everson-Hock E, Cantrell A, Stevenson M, Michaels J.Clinical effectiveness and cost-effectiveness of minimally invasive techniques to manage varicose veins: a systematic review and economic evaluation.Health Technol Assess. 2013 Oct;17(48):i-xvi, 1-141.

     

  11. Cavezzi A, Parsi K.Complications of foam sclerotherapy.Phlebology. 2012 Mar;27 Suppl 1:46-51. doi: 10.1258/phleb.2012.012S09. Review.

     

  12. Cavezzi A, Tessari L.Foam sclerotherapy techniques: different gases and methods of preparation, catheter versus direct injection.Phlebology. 2009 Dec;24(6):247-51. doi: 10.1258/phleb.2009.009061. Review.

     

  13. Coleridge Smith P.Foam and liquid sclerotherapy for varicose veins.Phlebology. 2009;24 Suppl 1:62-72. Review.

     

  14. Coleridge-Smith PD.Leg ulcer treatment.J Vasc Surg. 2009 Mar;49(3):804-8. Review.

     

  15. Foam Sclerotherapy for Treatment of Varicose Veins: A Review of the Clinical Effectiveness, Safety, Cost-Effectiveness, and Guidelines [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Feb 12. Available fromhttp://www.ncbi.nlm.nih.gov/books/NBK349766/

     

  16. Gibson K, Khilnani N, Schul M, Meissner M;American College of Phlebology Guidelines Committee. American College of Phlebology Guidelines – Treatment of refluxing accessory saphenous veins.Phlebology. 2017 Aug;32(7):448-452.

     

  17. Giordana P, Miserey G; Société française de médecine vasculaire.[French Society of Vascular Medicine good medical practice guidelines on safety and environment in vascular medicine: Treatment of varicose veins].J Mal Vasc. 2014 Dec;39(6):394-408.

     

  18. Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, Gillespie DL, Gloviczki ML, Lohr JM, McLafferty RB, Meissner MH, Murad MH, Padberg FT, Pappas PJ, Passman MA,Raffetto JD, Vasquez MA, Wakefield TW; Society for Vascular Surgery; American Venous Forum.The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum.J Vasc Surg. 2011 May;53(5 Suppl):2S-48S.

     

  19. Guex JJ.Complications and side-effects of foam sclerotherapy.Phlebology. 2009 Dec;24(6):270-4. doi: 10.1258/phleb.2009.009049. Review.

     

  20. Guex JJ.Foam sclerotherapy: an overview of use for primary venous insufficiency.Semin Vasc Surg. 2005 Mar;18(1):25-9. Review.

     

  21. Hamel-Desnos C, Allaert FA.Liquid versus foam sclerotherapy.Phlebology. 2009 Dec;24(6):240-6. doi: 10.1258/phleb.2009.009047. Review.

     

  22. Haruta N.Recent Progress of Varicose Vein Treatment Especially about Endovascular Heat Ablation, SEPS and Foam Sclerotherapy.Ann Vasc Dis. 2018 Mar 25;11(1):66-71. doi: 10.3400/avd.ra.18-00005. Review.

     

  23. Jia X, Mowatt G, Burr JM, Cassar K, Cook J, Fraser C.Systematic review of foam sclerotherapy for varicose veins.Br J Surg. 2007 Aug;94(8):925-36. Review.

     

  24. Kendler M, Wetzig T, Simon JC.Foam sclerotherapy–a possible option in therapy of varicose veins.J Dtsch Dermatol Ges. 2007 Aug;5(8):648-54. Review. English, German.

     

  25. Kheirelseid EAH, Crowe G, Sehgal R, Liakopoulos D, Bela H, Mulkern E, McDonnell C, O’Donohoe M.Systematic review and meta-analysis of randomized controlled trials evaluating long-term outcomes of endovenous management of lower¬†extremity varicose veins.J Vasc Surg Venous Lymphat Disord. 2018 Mar;6(2):256-270.

     

  26. Lawson JA, Toonder IM.A review of a new Dutch guideline for management of recurrent varicose veins.Phlebology. 2016 Mar;31(1 Suppl):114-24.

     

  27. Luebke T, Brunkwall J.Systematic review and meta-analysis of endovenous radiofrequency obliteration, endovenous laser therapy, and foam sclerotherapy for primary varicosis.J Cardiovasc Surg (Torino). 2008 Apr;49(2):213-33. Review.

     

  28. Meissner MH, Gloviczki P, Bergan J, Kistner RL, Morrison N, Pannier F, Pappas PJ, Rabe E, Raju S, Villavicencio JL.Primary chronic venous disorders.J Vasc Surg. 2007 Dec;46 Suppl S:54S-67S. doi: 10.1016/j.jvs.2007.08.038. Review.

     

  29. Mowatt-Larssen E.Management of secondary varicosities.Semin Vasc Surg. 2010 Jun;23(2):107-12. doi: 10.1053/j.semvascsurg.2010.01.006. Review.

     

  30. Murad MH, Coto-Yglesias F, Zumaeta-Garcia M, Elamin MB, Duggirala MK, Erwin PJ, Montori VM, Gloviczki P.A systematic review and meta-analysis of the treatments of varicose veins.J Vasc Surg. 2011 May;53(5 Suppl):49S-65S

     

  31. Myers KA, Roberts S.Evaluation of published reports of foam sclerotherapy: what do we know conclusively?Phlebology. 2009 Dec;24(6):275-80.

     

  32. National Clinical Guideline Centre (UK). Varicose Veins in the Legs: The Diagnosis and Management of Varicose Veins. London: National Institute for Health and Care Excellence (UK); 2013 Jul.
  33. Nesbitt C, Bedenis R, Bhattacharya V, Stansby G.Endovenous ablation (radiofrequency and laser) and foam sclerotherapy versus open surgery for great saphenous vein varices.Cochrane Database Syst Rev. 2014 Jul 30;(7):CD005624.

     

  34. Nesbitt C, Eifell RK, Coyne P, Badri H, Bhattacharya V, Stansby G.Endovenous ablation (radiofrequency and laser) and foam sclerotherapy versus conventional surgery for great saphenous vein varices. Cochrane Database Syst Rev. 2011 Oct 5;(10):CD005624. doi: 10.1002/14651858.CD005624.pub2.Review. Update in: Cochrane Database Syst Rev. 2014;7:CD005624.

     

  35. Palm MD, Guiha IC, Goldman MP.Foam sclerotherapy for reticular veins and nontruncal varicose veins of the legs: a retrospective review of outcomes and adverse effects.Dermatol Surg. 2010 Jun;36 Suppl 2:1026-33.

     

  36. Pannier F, Rabe E; for the Guideline Group.Results from RCTs in Sclerotherapy: European Guidelines for Sclerotherapy in Chronic Venous Disorders*.Phlebology. 2014 May;29(1 suppl):39-44. Epub 2014 May 19. Review.

     

  37. Paravastu SC, Horne M, Dodd PD. Endovenous ablation therapy (laser or radiofrequency) or foam sclerotherapy versus conventional surgical repair for short saphenous varicose veins. Cochrane Database Syst Rev. 2016 Nov 29;11:CD010878. Review. PubMed PMID: 27898181; PubMed Central PMCID: PMC6464398.
  38. Rabe E, Breu FX, Cavezzi A, Coleridge Smith P, Frullini A, Gillet JL, Guex JJ, Hamel-Desnos C, Kern P, Partsch B, Ramelet AA, Tessari L, Pannier F; Guideline Group.European guidelines for sclerotherapy in chronic venous disorders.Phlebology. 2014 Jul;29(6):338-54.

     

  39. Rabe E, Pannier F; for the Guideline Group.Indications, contraindications and performance: European Guidelines for Sclerotherapy in Chronic Venous Disorders.Phlebology. 2014 May;29(1 suppl):26-33. Epub 2014 May 19. Review.

     

  40. 40. Rabe E, Pannier F.Sclerotherapy in venous malformation.Phlebology. 2013 Mar;28 Suppl 1:188-91. doi: 10.1177/0268355513477282. Review.

     

  41. Rabe E, Pannier-Fischer F, Gerlach H, Breu FX, Guggenbichler S, Zabel M;German Society of Phlebology. Guidelines for sclerotherapy of varicose veins (ICD 10: I83.0, I83.1, I83.2, and I83.9).Dermatol Surg. 2004 May;30(5):687-93; discussion 693.

     

  42. Rathbun S, Norris A, Morrison N, Gibson K, Hohenwalter E, Lohr J, Raymond-Martimbeau P, Worthington-Kirsch R, Stoner J.Performance of endovenous foam sclerotherapy in the USA.Phlebology. 2012 Mar;27(2):59-66.

     

  43. Rathbun S, Norris A, Morrison N, Gibson K, Raymond-Martimbeau P, Worthington-Kirsch R, Hohenwalter E, Lohr J, McLafferty R, Stoner J.Performance of endovenous foam sclerotherapy in the USA for the treatment of venous disorders: ACP/SVM/AVF/SIR quality improvement guidelines.Phlebology. 2014 Mar;29(2):76-82.

     

  44. Rathbun S, Norris A, Stoner J.Efficacy and safety of endovenous foam sclerotherapy: meta-analysis for treatment of venous disorders.Phlebology. 2012 Apr;27(3):105-17.

     

  45. Simka M.Principles and technique of foam sclerotherapy and its specific use in the treatment of venous leg ulcers.Int J Low Extrem Wounds. 2011 Sep;10(3):138-45.

     

  46. St√cker M, Kobus S, Altmeyer P, Reich-Schupke S.Review of published information on foam sclerotherapy.Dermatol Surg. 2010 Jun;36 Suppl 2:983-92.

     

  47. Tisi PV, Beverley C, Rees A.Injection sclerotherapy for varicose veins.Cochrane Database Syst Rev. 2006 Oct 18;(4):CD001732. Review.

     

  48. Tripey V, Monsallier JM, Morello R, Hamel-Desnos C.French sclerotherapy and compression: Practice patterns.Phlebology. 2015 Oct;30(9):632-40.

     

  49. Vandendriessche M, Hobbs JT.The evolution of ultrasound guided foam sclerotherapy.Acta Chir Belg. 2008 Nov-Dec;108(6):660-5.

     

  50. Weiss MA, Hsu JT, Neuhaus I, Sadick NS, Duffy DM.Consensus for sclerotherapy.Dermatol Surg. 2014 Dec;40(12):1309-18.

     

  51. Wright DD.What is the current role of foam sclerotherapy in treating reflux and varicosities?Semin Vasc Surg. 2010 Jun;23(2):123-6. doi: 10.1053/j.semvascsurg.2010.01.009. Review.